USFDA completes inspection at Solara Active Pharma Sciences’ Mangalore facility

19 Nov 2025 Evaluate

Solara Active Pharma Sciences (Solara) has successfully completed the inspection carried out by the US Food and Drug Administration (USFDA) between August 25 and August 29, 2025 at Mangalore facility, Karnataka. The Agency has issued an EIR (Establishment Inspection Report) on November 18, 2025 and determined that the inspection classification of the facility is ‘Voluntary Action Indicated (VAI)’ and concluded this inspection as closed.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

547.35 -3.00 (-0.55%)
05-Dec-2025 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.90
Dr. Reddys Lab 1280.20
Cipla 1521.35
Zydus Lifesciences 933.70
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×